This morning Pfizer (PFE) announced the long rumored buyout/merger agreement with Ireland based maker of Botox, Allergen (AGN), valuing it at $160 billion. While cost cutting and empire building are at the heart of the …
Continue reading
In case you missed it, the two year chart of crude oil….. has been the inverse of the two year chart of the DXY, the US dollar index…. Yeah, I know you took your Econ back …
Continue reading
Here is a quick recap of trades that we initiated, closed, or debated in the week that was Nov 16th to Nov 20th:
Continue reading
Let me start by saying in the long run, I suspect it will be a costly strategy trying to make money betting against Elon Musk. But, Musk had a fairly noisy year in the three companies he is a large …
Continue reading
Since the start of QE and ZIRP, Don’t fight the Fed has been one of the most profitable consensus US equity trades of the last fifty years. In the last year, the Fed has ended …
Continue reading
Ten days ago we placed a somewhat contrarian trade in the utilities etf XLU. It has just sold off on renewed expectations of a Fed rate hike. It tends to outperform the rest of the …
Continue reading
Last night on CNBC’s Fast Money we discussed some yet to close large m&a deals announced this past year, where the target is trading well below the typical “closing risk” discount: I was asked to weigh …
Continue reading
Last night SalesForce.com (CRM) reported better than expected Q3 results and the stock is trading up 6%, breaking out of a seven month range to new all time highs: Today’s gains of about $3.5 billion …
Continue reading
Into potentially volatile events like earnings, specifically in stocks with high implied moves, and a history of post earnings movement, we like to offer what we deem to be dollar cheap hedges for those who …
Continue reading
Yesterday, prior to NetApp’s (NTAP) Q3 results, we previewed the event (here), and concluded that the stock’s cheap valuation, rock solid balance sheet, poor multi-year performance, prior activist interest and current m&a environment could make …
Continue reading